In Brussels, European Commissioners Jyrki Katainen and Carlos Moedas proposed a budget increase of 25% for the next European Research and Innovation programme Horizon Europe (2021-27) compared to Horizon 2020. Insummer, however, the EC’s High LevelGroup recommended a budget of at least €120bn.
EC earmarks €97.6m for Horizon
BackgroundIn Brussels, European Commissioners Jyrki Katainen and Carlos Moedas proposed a budget increase of 25% for the next European Research and Innovation programme Horizon Europe (2021-27) compared to Horizon 2020. Insummer, however, the EC’s High LevelGroup recommended a budget of at least €120bn.
VarmX raises €12.5m
Latest NewsVarmX will use the combination of a €7.5m Series A financing co-led by BioGeneration Ventures (BGV) and Dutch regional development company InnovationQuarter plus an €5m innovation credit from the Netherlands Enterprise Agency (RVO.nl) to develop a modified blood coagulation factor X to prevent severe bleeding in haemophilia patients.
CHMP greenlights first two CAR-T cell therapies in the EU
Latest NewsThe EMA’s CHMP recommended nine medicines including six orphan medicines for EU market approval on Friday.
Corbion CEO de Ruiter named new EuropaBio Chairman
AppointmentsEuropaBio’s Executive Board and General Assembly of Members this week confirmed the appointment of Tjerk de Ruiter as Chairman of the association.
Symcel appoints two new board members
AppointmentsSymcel has announced the appointment of two new board members; Erik Walldén and Stefan Löfås. Both will play a key role in the company’s corporate strategy to grow business in the research market and develop solutions for clinical diagnostics.
Improving models of chronic hepatitis
Latest NewsGerman and US researchers have designed a mouse model that exactly mimics the mechanisms of hepatitis infection in men.
GMO acreage growing globally
Latest NewsAgribiotech lobby group ISAAA reports that global GMO acreage has grown to 189.8 million hectares in 2017 -3% or 4.7 million hectares more than in 2016.
Chugai ends licence for PharmaMar’s lurbinectedin
Latest NewsRoche’s Japanese arm Chugai today returned all rights from a 2016 licence agreement on the RNA polymerase II blocker lurbinectedin to Spanish oncology specialist PharmaMar SA.
Microbial game-changers
BackgroundHow do novel technologies affect the world’s largest enzyme producer? At the GBS, European Biotechnology asked Thomas Videbaeck, PhD, COO and Executive VP Research, Innovation and Supply.
Inflammasome specialist NodThera Ltd raises €31.8m
Latest NewsSelvita spin-out NodThera Ltd raised £28 million (€31.8m) in a Series A financing round led by Sofinnova Partners and 5AM Ventures and co-financed by Epidarex Capital and F-Prime Capital Partners.